The first practice parameters published on amyotrophic lateral sclerosis (ALS) by the American Academy of Neurology (AAN) enhanced the care of people with this condition. These guidelines have now been updated on the basis of new evidence and will continue to provide the impetus for new research and better care; however, harmonization of the AAN and European guidelines is desirable.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Miller, R. G. et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 52, 1311–1323 (1999).
Andersen, P. M. et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur. J. Neurol. 12, 921–938 (2005).
Heffernan, C. et al. Nutritional management in MND/ALS patients: an evidence based review. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 5, 72–83 (2004).
Heffernan, C. et al. Management of respiration in MND/ALS patients: an evidence based review. Amyotroph. Lateral Scler. 7, 5–15 (2006).
Miller, R. G. et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73, 1218–1226 (2009).
Miller, R. G. et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73, 1227–1233 (2009).
Bensimon, G. et al. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS Study. Brain 132, 156–171 (2009).
Landwehrmeyer, G. B. et al. Riluzole in Huntington's disease: a 3-year, randomized controlled study. Ann. Neurol. 62, 262–272 (2007).
Bourke, S. C. et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 5, 140–147 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
P. N. Leigh has received honoraria from GlaxoSmithKline, and Sanofi-aventis for lectures and honoraria from Acceleron Pharma, GlaxoSmithKline, NeuroNova, Sanofi-aventis, and Trophos for consulting. He has also received research funding from GlaxoSmithKline, Sanofi-aventis and Trophos. L. C. Wijesekera declares no competing interests.
Supplementary information
Supplementary Table 1
Comparison of respiratory and nutritional management guidelines for ALS (DOC 84 kb)
Rights and permissions
About this article
Cite this article
Leigh, P., Wijesekera, L. Focusing the mind on ALS: updated practice parameters. Nat Rev Neurol 6, 191–192 (2010). https://doi.org/10.1038/nrneurol.2010.33
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2010.33
